Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
Roger S. McIntyre, Marie‐Josée Filteau, Lawrence Martin, et al.
Journal of Affective Disorders (2013) Vol. 156, pp. 1-7
Closed Access | Times Cited: 385

Showing 1-25 of 385 citing articles:

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
Sidney H. Kennedy, Raymond W. Lam, Roger S. McIntyre, et al.
The Canadian Journal of Psychiatry (2016) Vol. 61, Iss. 9, pp. 540-560
Open Access | Times Cited: 945
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Martin A. Katzman, Timothy S. Bilkey, Pratap Chokka, et al.
BMC Psychiatry (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 522
The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States
Maryia Zhdanava, Dominic Pilon, Isabelle Ghelerter, et al.
The Journal of Clinical Psychiatry (2021) Vol. 82, Iss. 2
Open Access | Times Cited: 316
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, et al.
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 394-412
Open Access | Times Cited: 256
The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature
Karissa Johnston, Lauren Powell, Ian Anderson, et al.
Journal of Affective Disorders (2018) Vol. 242, pp. 195-210
Closed Access | Times Cited: 254
Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications
Manoj P. Dandekar, Albert J. Fenoy, André F. Carvalho, et al.
Molecular Psychiatry (2018) Vol. 23, Iss. 5, pp. 1094-1112
Closed Access | Times Cited: 243
Pragmatic randomized controlled trial of long‐term psychoanalytic psychotherapy for treatment‐resistant depression: the Tavistock Adult Depression Study (TADS)
Peter Fonagy, Felicitas Rost, J. B. W. Carlyle, et al.
World Psychiatry (2015) Vol. 14, Iss. 3, pp. 312-321
Open Access | Times Cited: 218
Reinforcement learning in depression: A review of computational research
Chong Chen, Taiki Takahashi, Shin Nakagawa, et al.
Neuroscience & Biobehavioral Reviews (2015) Vol. 55, pp. 247-267
Closed Access | Times Cited: 203
Pharmacological approaches to the challenge of treatment-resistant depression
Dawn F. Ionescu, Jerrold F. Rosenbaum, Jonathan E. Alpert
Dialogues in Clinical Neuroscience (2015) Vol. 17, Iss. 2, pp. 111-126
Open Access | Times Cited: 185
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 154
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
Fernanda S. Correia‐Melo, Gustavo C. Leal, Flávia Vieira, et al.
Journal of Affective Disorders (2019) Vol. 264, pp. 527-534
Closed Access | Times Cited: 148
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
Luca Sforzini, Courtney Worrell, Melisa Kose, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 3, pp. 1286-1299
Open Access | Times Cited: 137
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis
Nicolás A. Núñez, Boney Joseph, Mehak Pahwa, et al.
Journal of Affective Disorders (2022) Vol. 302, pp. 385-400
Open Access | Times Cited: 125
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)
Giovanni Martinotti, Antonio Vita, Andrea Fagiolini, et al.
Journal of Affective Disorders (2022) Vol. 319, pp. 646-654
Closed Access | Times Cited: 72
A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
Stuart J. Eisendrath, Erin Gillung, Kevin Delucchi, et al.
Psychotherapy and Psychosomatics (2016) Vol. 85, Iss. 2, pp. 99-110
Open Access | Times Cited: 164
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 143
Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments
Elisa Brietzke, Rodrigo B. Mansur, Mehala Subramaniapillai, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 94, pp. 11-16
Closed Access | Times Cited: 141
Psychological therapies for treatment-resistant depression in adults
Sharea Ijaz, Philippa Davies, Catherine J. Williams, et al.
Cochrane library (2018) Vol. 2018, Iss. 8
Open Access | Times Cited: 133
The Prevalence, Measurement, and Treatment of the Cognitive Dimension/Domain in Major Depressive Disorder
Roger S. McIntyre, Holly X. Xiao, Kahlood Syeda, et al.
CNS Drugs (2015) Vol. 29, Iss. 7, pp. 577-589
Closed Access | Times Cited: 126
Trazodone for Insomnia: A Systematic Review.
Karim Yahia Jaffer, Tiffany Chang, Brigitte Vanle, et al.
PubMed (2018) Vol. 14, Iss. 7-8, pp. 24-34
Closed Access | Times Cited: 122
Esketamine for treatment resistant depression
Jennifer Swainson, Rejish K. Thomas, Shaina Archer, et al.
Expert Review of Neurotherapeutics (2019) Vol. 19, Iss. 10, pp. 899-911
Closed Access | Times Cited: 110
Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment
Zhen Ren, Horia Pribiag, Sarah J. Jefferson, et al.
Biological Psychiatry (2016) Vol. 80, Iss. 6, pp. 457-468
Open Access | Times Cited: 108
Combination Therapy with Monoamine Oxidase Inhibitors and Other Antidepressants or Stimulants: Strategies for the Management of Treatment‐Resistant Depression
Samantha J. Thomas, Mi-Rae Shin, Melvin G. McInnis, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2015) Vol. 35, Iss. 4, pp. 433-449
Open Access | Times Cited: 100
Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials
Ana Sofia Vargas, Ângelo Luís, Mário Barroso, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 331-331
Open Access | Times Cited: 99
Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
Yoav Domany, Maya Bleich‐Cohen, Ricardo Tarrasch, et al.
The British Journal of Psychiatry (2018) Vol. 214, Iss. 1, pp. 20-26
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top